Back
Novartis AG Vs. Akero Therapeutics Industry Stock Comparison
Buy
60
NVS
Novartis AG
Last Price:
103.84
Seasonality Move:
1.51%
Buy
61
AKRO
Akero Therapeutics
Last Price:
31.22
Seasonality Move:
5.92%
Buy
60
Novartis AG (NVS)
is a Buy
Is Novartis AG a Buy, Sell or Hold?
- The current Novartis AG [NVS] share price is $103.09. The Score for NVS is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- NVS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
61
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
- The current Akero Therapeutics [AKRO] share price is $30.64. The Score for AKRO is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- AKRO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NVS Stock Price Chart
What is Novartis AG's stock price today?
-
The Novartis AG share price today is $103.09
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVS is experiencing buying pressure, which is a positive indicator for future bullish movement.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $30.64
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing slight selling pressure.
NVS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.93 | Sell |
| Relative Strength Index (14 RSI): | 24.7 | Sell |
| Chaikin Money Flow: | 761285 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (104.47 - 113.87) | Sell |
| Bollinger Bands (100): | (108.1 - 117) | Sell |
AKRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.2 | Buy |
| Relative Strength Index (14 RSI): | 49.43 | Sell |
| Chaikin Money Flow: | -52673 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.33 - 33.05) | Sell |
| Bollinger Bands (100): | (24.84 - 30.44) | Buy |
NVS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 103.79 | Sell |
| 20-day SMA: | 107.56 | Sell |
| 50-day SMA: | 112.31 | Sell |
| 200-day SMA: | 106.39 | Sell |
| 8-day EMA: | 104.12 | Sell |
| 20-day EMA: | 106.99 | Sell |
| 50-day EMA: | 110.35 | Sell |
| 200-day EMA: | 107.81 | Sell |
AKRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.68 | Sell |
| 20-day SMA: | 31.41 | Sell |
| 50-day SMA: | 29.63 | Buy |
| 200-day SMA: | 25.21 | Buy |
| 8-day EMA: | 30.77 | Sell |
| 20-day EMA: | 30.97 | Sell |
| 50-day EMA: | 29.78 | Buy |
| 200-day EMA: | 27.2 | Buy |
Novartis AG Earnings Growth & NVS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.95 per share, and an increase next year of $0.72 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.08 per share, and a decrease next year of $0.90 per share.
Novartis AG Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Akero Therapeutics Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||